THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.qduh.cn

Clinical Trials

A Phase I Clinical Study on SHR6390 in Healthy Chinese Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: SHR6390(100mg)
Drug: SHR6390(125mg)
Drug: SHR6390(150mg)

First Posted Date: 2022-04-29

Last Posted Date: 2022-05-05

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 36

Registration Number: NCT05354336

Locations: 🇨🇳
Phase I Clinical Research Center, Qingdao, Shandong, China

Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer

Not Applicable

Active, not recruiting

Conditions: Stomach Neoplasms
Frail Elderly

Interventions: Behavioral: ERAS protocol
Behavioral: Multimodal prehabilitation program

First Posted Date: 2022-04-29

Last Posted Date: 2024-12-13

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 368

Registration Number: NCT05352802

Locations: 🇨🇳
Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital, Qingdao, Shandong, China

Intrawound Administration of Vancomycin in TKA

Not Applicable

Completed

Conditions: Knee Osteoarthritis

Interventions: Procedure: Intrawound administration of vancomycin after closure of the arthrotomy

First Posted Date: 2022-04-20

Last Posted Date: 2023-01-19

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 100

Registration Number: NCT05338021

Locations: 🇨🇳
The affiliated hospital of Qingdao University, Qingdao, Shandong, China

Intrawound Administration of Vancomycin in THA

Not Applicable

Completed

Conditions: Hip

Interventions: Procedure: Intrawound administration of vancomycin after closure of the arthrotomy

First Posted Date: 2022-04-20

Last Posted Date: 2023-01-19

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 40

Registration Number: NCT05338008

Locations: 🇨🇳
The affiliated hospital of Qingdao University, Qingdao, Shandong, China

Pharmacokinetics and Bioavailability of Curcumin UP 30 Capsules in Healthy Adult Subjects

Phase 1

Conditions: Healthy Adult Subjects

Interventions: Drug: CuminUP30
Drug: Curcumin capsules

First Posted Date: 2022-04-19

Last Posted Date: 2022-04-19

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 12

Registration Number: NCT05334043

Locations: 🇨🇳
Phase I Clinical Research Center, Qingdao, Shanndong, China

Comparative Study on Tolerance and Pharmacokinetics of Voriconazole for Injection in Healthy Subjects

Phase 1

Completed

Conditions: Healthy Adults

Interventions: Drug: 4 mg/kg Voriconazole
Drug: 6 mg/kg Voriconazole

First Posted Date: 2022-04-15

Last Posted Date: 2022-04-15

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 48

Registration Number: NCT05330000

Locations: 🇨🇳
Phase I Clinical Research Center, Qingdao, Shanndong, China

Femoral External Rotation Measured on CT and MRI

Conditions: Knee Osteoarthritis

Interventions: Other: CT and MRI

First Posted Date: 2022-04-14

Last Posted Date: 2022-04-21

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 100

Registration Number: NCT05327413

Locations: 🇨🇳
The affiliated hospital of Qingdao University, Qingdao, Shandong, China

Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases

Conditions: Rituximab
Blood Disease
Children

Interventions: Drug: Rituximab (once a week)
Drug: Rituximab

First Posted Date: 2022-04-13

Last Posted Date: 2022-04-13

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 20

Registration Number: NCT05324917

PD-L1 Inhibitor Rechallenge After PD-1 Immunotherapy for Patients With Solid Tumor Beyond Lung Cancer

Phase 1

Conditions: Efficacy
Safety

Interventions: Drug: PD-L1 inhibitor

First Posted Date: 2022-04-13

Last Posted Date: 2022-04-13

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 30

Registration Number: NCT05325684

To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout

Phase 1

Conditions: Gout

Interventions: Drug: Colchicine

First Posted Date: 2022-04-12

Last Posted Date: 2022-05-09

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 20

Registration Number: NCT05324423

Locations: 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy